Skip to content Skip to footer

Renal Pathology with Clinical Correlations:
An Evening for Nephrologists and Nephrology Fellows
April 2, 2009

On Thursday, April 2, 2009 KUFA hosted Renal Pathology with Clinical Correlations – An Evening for Nephrologists and Nephrology Fellows at the Stony Hill Inn in Hackensack, NJ. The program was Co-Chaired by Alexandre S. Ackad, MD, Hackensack University Medical Center; Bergen Hypertension & Renal Associates PA, Midland Park, NJ and Robert S. Rigolosi, MD, Director of Department of Medical Education, Director of Regional Hemodialysis Center, Holy Name Hospital, Teaneck, NJ.

Discussion of pathology and biopsy results were led by two distinguished pathologists: Surya V. Seshan, MD, Chief, Renal Pathology, New York Presbyterian Hospital; Professor of Pathology, Weill Medical College of Cornell University, New York, NY and KUFA Scientific Advisory Board member, and Glen S. Markowitz, MD, Professor of Clinical Pathology & Cell Biology, Columbia University Medical Center, New York, NY. Clinical histories were presented by: Chandra B. Chandran, MD, Chief of Nephrology, St. Joseph�s Regional Medical Center, Paterson, NJ; Thomas L. Salazer, MD, Hackensack University Medical Center, Hackensack, NJ; Holy Name Hospital, Teaneck, NJ; Englewood Hospital & Medical Center, Englewood, NJ; Howard B. Weizman, MD, Hackensack University Medical Center, Hackensack, NJ; Valley Hospital, Ridgewood, NJ and Alexander M. Vitievsky, MD, Holy Name Hospital, Teaneck, NJ; Valley Hospital, Ridgewood, NJ; Hackensack University Medical Center, Hackensack, NJ.

This session aimed to identify clinical variabilities of disease processes and diagnostic pathologic findings of glomerular, tubulo-interstitial and vascular diseases in native and transplant kidney biopsies. Development of differential diagnoses of renal and multi-systemic diseases affecting the kidney, as well as new therapies and protocol, based on clinical and pathologic data were discussed.

http://www.kidneyurology.org/events/renalpathology/

This meeting was supported by an educational grant from Genzyme Therapeutics.